Bridge to recovery in two cases of dilated cardiomyopathy after long-term mechanical circulatory support

Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery
Jerzy PacholewiczMarian Zembala

Abstract

Ventricular assist devices (VADs) have become an established therapeutic option for patients with end-stage heart failure. Achieving the potential for recovery of native heart function using VADs is an established form of treatment in a selected group of patients with HF. We report two cases of VAD patients with different types of pump used for mechanical circulatory support, a continuous flow pump (Heart-Ware(®)) and a pulsatile pump (POLVAD MEV(®)), which allow regeneration of the native heart. Patients were qualified as INTERMACS level 3-4 for elective implantation of an LVAD. Implantations were performed without complications. The postoperative course was uncomplicated. In the HeartWare patient the follow-up was complicated by episodes of epistaxis and recurrent GIB as well as driveline infection. The follow-up of the POLVAD MEV patient was uneventful. Recurrent GIB forced us to withdraw aspirin and warfarin therapy and maintain only clopidogrel in the HeartWare patient.. In mid-February 2013 the patient was admitted due to dysfunction of the centrifugal pump with a continuous low-flow alarm and increase power consumption. Under close monitoring of the patient a decision was made to stop the pump immediately and evaluate ca...Continue Reading

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapy

Software Mentioned

POLVAD

Related Concepts

Related Feeds

Artificial Heart & Ventricular Assist Devices

Total artificial hearts (TAH) and ventricular assist devices (VADs) provide cardiac support for patients with end-stage heart disease and have significantly improved the survival of these patients. Discover the latest research on Artificial Heart and Ventricular Assist Devices here.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Cardiac Regeneration

Cardiac regeneration enables the repair of irreversibly damaged heart tissue using cutting-edge science, including stem cell and cell-free therapy. Discover the latest research on cardiac regeneration here.

Related Papers

The Thoracic and Cardiovascular Surgeon
C SchlensakF Beyersdorf
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
Avinash ChandraPaul J Mather
Journal of Artificial Organs : the Official Journal of the Japanese Society for Artificial Organs
Anton SabashnikovAndre Ruediger Simon
© 2021 Meta ULC. All rights reserved